Sonnet Historical Cash Flow
| SONN Stock | USD 1.91 0.07 3.54% |
Analysis of Sonnet Biotherapeutics cash flow over time is an excellent tool to project Sonnet Biotherapeutics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 5.1 K or Other Cashflows From Financing Activities of 2.1 M as it is a great indicator of Sonnet Biotherapeutics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Sonnet Biotherapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Sonnet Biotherapeutics is a good buy for the upcoming year.
Sonnet |
About Sonnet Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Sonnet balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Sonnet's non-liquid assets can be easily converted into cash.
Sonnet Biotherapeutics Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Sonnet Biotherapeutics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Sonnet Biotherapeutics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Sonnet Biotherapeutics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Sonnet Biotherapeutics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonnet Biotherapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Sonnet Biotherapeutics' Total Cashflows From Investing Activities is very stable compared to the past year. As of the 12th of December 2024, Cash Flows Other Operating is likely to grow to about 2 M, while Sale Purchase Of Stock is likely to drop about 167.2 K.
Sonnet Biotherapeutics cash flow statement Correlations
Click cells to compare fundamentals
Sonnet Biotherapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Sonnet Biotherapeutics cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Begin Period Cash Flow | 438.5K | 5.4K | 7.3M | 27.6M | 3.1M | 5.1K | |
| Capital Expenditures | 1.7M | 2.4M | 3.6K | 896.5K | 443.3K | 2.5M | |
| Total Cash From Operating Activities | (1.1M) | (2.2M) | (22.6M) | (27.7M) | (21.3M) | (2.3M) | |
| End Period Cash Flow | 524.1K | 35.7K | 27.6M | 3.1M | 2.3M | 33.9K | |
| Net Borrowings | 303.3K | (355.2K) | (526.1K) | (20.4K) | (473.5K) | (449.8K) | |
| Total Cashflows From Investing Activities | (2.4M) | 678.7K | (3.6K) | (896.5K) | 780.5K | 819.5K | |
| Change To Netincome | 1.5M | 8.6M | 1.3M | 1.8M | 9.9M | 10.4M | |
| Change To Liabilities | 2.6M | 155.9K | 1.7M | 621.1K | 179.3K | 170.3K |
Pair Trading with Sonnet Biotherapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sonnet Biotherapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Sonnet Stock
Moving against Sonnet Stock
| 0.93 | BMY | Bristol Myers Squibb | PairCorr |
| 0.81 | ESPR | Esperion Therapeutics | PairCorr |
| 0.8 | GILD | Gilead Sciences | PairCorr |
| 0.56 | DYAI | Dyadic International | PairCorr |
| 0.43 | DNA | Ginkgo Bioworks Holdings | PairCorr |
The ability to find closely correlated positions to Sonnet Biotherapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sonnet Biotherapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sonnet Biotherapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sonnet Biotherapeutics Holdings to buy it.
The correlation of Sonnet Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sonnet Biotherapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sonnet Biotherapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sonnet Biotherapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonnet Biotherapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sonnet Biotherapeutics. If investors know Sonnet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sonnet Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.96) | Revenue Per Share 0.019 | Quarterly Revenue Growth (0.50) | Return On Assets (0.97) | Return On Equity (2.65) |
The market value of Sonnet Biotherapeutics is measured differently than its book value, which is the value of Sonnet that is recorded on the company's balance sheet. Investors also form their own opinion of Sonnet Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sonnet Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sonnet Biotherapeutics' market value can be influenced by many factors that don't directly affect Sonnet Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sonnet Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sonnet Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sonnet Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.